Downsizing the CDC, FDA, and NIH weakens our ability to fight deadly outbreaks like Ebola, which, without early detection and treatment, has a 90% fatality rate. The 2014-2016 crisis proved these agencies are critical. Cutting funding risks slower responses and more lives lost.